FibroGen
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of FibroGen generated cash of -$315,021,000, which is less than the previous year. Cash used in financing activities reached the amount of $122,749,000 last year. Net change in cash is therefore -$42,012,000.
Cash Flow
| 2014 | 22.41M | -107.28M | 174.09M |
|---|---|---|---|
| 2015 | -18.57M | -5.86M | 12.34M |
| 2016 | 7.10M | 6.62M | 6.73M |
| 2017 | -66.51M | 69.86M | 496.47M |
| 2018 | -76.14M | -522.12M | 13.87M |
| 2019 | -78.70M | 120.01M | -4.3M |
| 2020 | 81.60M | 452.48M | 13.34M |
| 2021 | -82.23M | -426.97M | -563K |
| 2022 | -145.93M | 89.11M | 46.77M |
| 2023 | -315.02M | 153.65M | 122.74M |
FGEN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 155.7M | 171.22M | 678.39M | 126.26M | 89.25M | 673.65M | 173.78M | 153.32M | 165.45M | 76.33M |
Operating activities | ||||||||||
Net income | -284.23M | -293.65M | -290.02M | -189.29M | -76.97M | -86.42M | -126.20M | -61.68M | -85.77M | -59.50M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 9.93M | 10.60M | 14.80M | 22.04M | 21.45M | 6.56M | 6.09M | 6.04M | 5.67M | 4.47M |
Stock-based compensation expense | 50.76M | 65.60M | 71.16M | 72.72M | 66.26M | 0 | 37.53M | 32.13M | 27.68M | 18.69M |
| Deferred income tax benefit | 50.76M | 65.60M | 71.16M | 72.72M | 66.26M | 0 | 37.53M | 32.13M | 27.68M | 18.69M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 3.43M | 765K | 25.18M | -11.97M | 35.22M | -55.23M | 1.99M | 4.95M | -1.95M | 4.04M |
Inventories | -1.69M | -10.99M | -14.15M | -9.17M | -6.88M | 8.23M | 7.56M | 6.63M | 3.28M | 17.01M |
Accounts payable | -15.51M | 5.90M | 805K | 17.73M | -3.05M | 3.63M | -714K | -298K | 1.97M | 3.48M |
Cash generated by operating activities | -315.02M | -145.93M | -82.23M | 81.60M | -78.70M | -76.14M | -66.51M | 7.10M | -18.57M | 22.41M |
Investing activities | ||||||||||
Purchases Of Investments | -251.83M | -164.02M | -484.14M | -8.19M | -411.29M | -576.88M | -169K | -9.04M | -41.73M | -144.72M |
Investments In Property Plant And Equipment | -2.51M | -38.74M | -30.18M | -3.99M | -5.76M | -8.02M | -8.5M | -1.25M | -1.97M | -8.11M |
Acquisitions Net | 656K | 6K | 25M | -3.89M | 7K | 0 | 5K | -6.62M | 2K | 0 |
Cash generated by investing activities | 153.65M | 89.11M | -426.97M | 452.48M | 120.01M | -522.12M | 69.86M | 6.62M | -5.86M | -107.28M |
Financing activities | ||||||||||
Common Stock Issued | 48.40M | 4.18M | 12.70M | 37.82M | 20.77M | 29.84M | 506.11M | 9.88M | 14.99M | 155.93M |
Payments for dividends | -2.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -5.16M | -7.37M | -11.46M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 73.59M | -538K | -5.89M | -13.02M | -12.32M | -409K | -403K | -403K | -403K | -403K |
Cash used in financing activities | 122.74M | 46.77M | -563K | 13.34M | -4.3M | 13.87M | 496.47M | 6.73M | 12.34M | 174.09M |
Net Change In Cash | -42.01M | -15.52M | -507.17M | 552.12M | 37.00M | -584.4M | 499.87M | 20.45M | -12.13M | 89.12M |
Cash at end of period | 113.68M | 155.7M | 171.22M | 678.39M | 126.26M | 89.25M | 673.65M | 173.78M | 153.32M | 165.45M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |